Naftidrofuryl oxalate - Peripheral arterial disease
You are here : Home > Formulary Search > Naftidrofuryl oxalate - Peripheral arterial disease
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Documentation
NICE Technology Appraisal
PAD Profile
ChemicalSubstance :
Naftidrofuryl oxalate
Indication :
Peripheral arterial disease
Group Name :
Keywords :
Intermittent claudication, peripheral vascular disease, atherosclerosis,
Brand Names Include :
Praxilene
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1
Committee Recommendations (1)
GENERIC Naftidrofuryl has been considered by the PCN and has been assigned a GREEN traffic light status.
NOTE - the branded product, Praxilene, was considered BLACK at the PCN in May 2017.
NOTE - the branded product, Praxilene, was considered BLACK at the PCN in May 2017.
Other Indications
Below are listed other indications that Naftidrofuryl oxalate is used to treat.
- No records returned.
Other Drugs
Below are listed other drugs that are used to treat Peripheral arterial disease.